HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Liu, M. Articles by Subbaiah, P. V. Search for Related Content PubMed PubMed Citation Articles by Liu, M. Articles by Subbaiah, P. V. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol 36, 1813-1824, Copyright © 1995 by Lipid Research, Inc.

ARTICLES

Specificity of lecithin:cholesterol acyltransferase and atherogenic risk: comparative studies on the plasma composition and in vitro synthesis of cholesteryl esters in 14 vertebrate species

M Liu, JD Bagdade and PV Subbaiah
Department of Medicine, Rush Medical College, Chicago, IL 60612, USA.

To determine whether the specificity of lecithin: cholesterol acyltransferase (LCAT) influences the susceptibility to atherosclerosis, we compared the composition and in vitro synthesis of cholesteryl ester (CE) in the plasmas of 14 vertebrate species with varying predisposition to atherosclerosis. The susceptible species (Group I) had significantly higher ratios of 16:0 CE/20:4 CE in their plasma than the resistant species (Group II). The in vitro formation of labeled CE species in native plasma from labeled cholesterol correlated highly with the mass composition, showing that the LCAT reaction is the predominant source of plasma CE in all the animal species examined. Isolated LCATs from Group I species also synthesized CE with higher ratios of 16:0/20:4 than LCATs from Group II when egg phosphatidylcholine (PC) was used as the acyl donor. In addition, the Group I LCATs exhibited lower specificity towards sn-2-20:4 and sn-2- 22:6 PCs, and higher specificity towards sn-2-18:2 PC species than Group II LCATs. With 16:0-20:4 PC as the substrate, all Group I LCATs synthesized more 16:0 CE than 20:4 CE, whereas all Group II LCATs, with the exception of dog enzyme, synthesized predominantly 20:4 CE, showing that the two types of LCAT have different positional specificities towards this PC. These results suggest that there are two classes of LCAT in nature that differ from each other in their substrate and positional specificities, possibly because of differences in their active-site architectures. We propose that the presence of one type of LCAT, which cannot efficiently transfer certain long chain polyunsaturated acyl groups and which consequently synthesizes more saturated CE, may increase the risk of atherosclerosis.
CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A. Yesilaltay, M. G. Morales, L. Amigo, S. Zanlungo, A. Rigotti, S. L. Karackattu, M. H. Donahee, K. F. Kozarsky, and M. Krieger Effects of Hepatic Expression of the High-Density Lipoprotein Receptor SR-BI on Lipoprotein Metabolism and Female Fertility Endocrinology, April 1, 2006; 147(4): 1577 - 1588. [Abstract] [Full Text] [PDF]

				Y. Zhao, A. K. Gebre, and J. S. Parks Amino acids 149 and 294 of human lecithin:cholesterol acyltransferase affect fatty acyl specificity J. Lipid Res., December 1, 2004; 45(12): 2310 - 2316. [Abstract] [Full Text] [PDF]

				P. V. Subbaiah, J. M. Sowa, and M. H. Davidson Evidence for altered positional specificity of LCAT in vivo: studies with docosahexaenoic acid feeding in humans J. Lipid Res., December 1, 2004; 45(12): 2245 - 2251. [Abstract] [Full Text] [PDF]

				L. Zhou and A. Nilsson Sources of eicosanoid precursor fatty acid pools in tissues J. Lipid Res., October 1, 2001; 42(10): 1521 - 1542. [Abstract] [Full Text] [PDF]

				J. W. Furbee Jr., O. Francone, and J. S. Parks Alteration of plasma HDL cholesteryl ester composition with transgenic expression of a point mutation (E149A) of human LCAT J. Lipid Res., October 1, 2001; 42(10): 1626 - 1635. [Abstract] [Full Text] [PDF]

				P. V. Subbaiah, V. S. Subramanian, and M. Liu Trans unsaturated fatty acids inhibit lecithin: cholesterol acyltransferase and alter its positional specificity J. Lipid Res., July 1, 1998; 39(7): 1438 - 1447. [Abstract] [Full Text]

				M. Liu, R. W. St. Clair, and P. V. Subbaiah Impaired function of lecithin:cholesterol acyltransferase in atherosclerosis-susceptible White Carneau pigeons: possible effects on metabolism of oxidized phospholipids J. Lipid Res., February 1, 1998; 39(2): 245 - 254. [Abstract] [Full Text]

				S. M. Innis and R. Dyer Dietary Triacylglycerols with Palmitic Acid (16:0) in the 2-Position Increase 16:0 in the 2-Position of Plasma and Chylomicron Triacylglycerols, but Reduce Phospholipid Arachidonic and Docosahexaenoic Acids, and Alter Cholesteryl Ester Metabolism in Formula-Fed Piglets J. Nutr., July 1, 1997; 127(7): 1311 - 1319. [Abstract] [Full Text]

				J. Wang, A. K. Gebre, R. A. Anderson, and J. S. Parks Amino Acid Residue 149of Lecithin:Cholesterol Acyltransferase Determines Phospholipase A2 and Transacylase Fatty Acyl Specificity J. Biol. Chem., January 3, 1997; 272(1): 280 - 286. [Abstract] [Full Text] [PDF]

				S. Seguret-Mace, M. Latta-Mahieu, G. Castro, G. Luc, J.-C. Fruchart, E. Rubin, P. Denefle, and N. Duverger Potential Gene Therapy for Lecithin-Cholesterol Acyltransferase (LCAT)–Deficient and Hypoalphalipoproteinemic Patients With Adenovirus-Mediated Transfer of Human LCAT Gene Circulation, November 1, 1996; 94(9): 2177 - 2184. [Abstract] [Full Text]